The Antiparasitic Drugs Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including by Drug Type (Anthelmintics, Antiprotozoals, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others).
The Antiparasitic Drugs Market is expected to witness significant growth in 2024 due to the increasing prevalence of parasitic infections, rising awareness about neglected tropical diseases, and advancements in drug development technologies. Antiparasitic drugs play a crucial role in the treatment and management of various parasitic infections caused by protozoa, helminths, and ectoparasites, including malaria, leishmaniasis, trypanosomiasis, schistosomiasis, and soil-transmitted helminthiasis.
Key factors driving the growth of the antiparasitic drugs market include the expanding global burden of parasitic diseases, particularly in low- and middle-income countries with limited access to healthcare services, sanitation, and clean water sources. Moreover, the increasing investment in tropical disease research, drug discovery initiatives, and public health interventions by governments, non-governmental organizations, and international agencies contribute to market growth and adoption of antiparasitic therapies.
In addition, technological advancements in drug delivery systems, formulation techniques, and pharmacogenomics enhance the efficacy, safety, and tolerability of antiparasitic drugs while minimizing adverse effects and drug resistance. In addition, the emergence of novel drug targets, therapeutic strategies, and combination therapies offers new treatment options and therapeutic modalities for patients with parasitic infections. Moreover, strategic collaborations, partnerships, and funding support for research and development activities accelerate drug development timelines and expand market reach globally.
A prominent trend in the antiparasitic drugs market is the rising prevalence of parasitic infections worldwide. Parasitic diseases, caused by organisms such as protozoa, helminths, and ectoparasites, continue to pose significant public health challenges globally, particularly in tropical and subtropical regions. Factors such as population growth, urbanization, travel, climate change, and inadequate sanitation contribute to the spread of parasitic infections. As a result, there is an increasing demand for effective antiparasitic drugs to prevent, treat, and control parasitic diseases, driving growth in the market.
A significant driver in the antiparasitic drugs market is the growing awareness and focus on neglected tropical diseases (NTDs). NTDs are a group of parasitic and other infectious diseases that primarily affect populations in low-resource settings, often marginalized and underserved communities. Organizations such as the World Health Organization (WHO) and non-governmental organizations (NGOs) have intensified efforts to combat NTDs through various initiatives, including mass drug administration programs, improved access to healthcare, and research and development of new antiparasitic drugs. The increased attention to NTDs and the implementation of control and elimination programs drive demand for antiparasitic drugs and stimulate investment in the market.
An exciting potential opportunity in the antiparasitic drugs market lies in the development of novel drugs with improved safety and efficacy profiles. While existing antiparasitic drugs have been instrumental in treating many parasitic infections, challenges such as drug resistance, adverse effects, and limited treatment options remain significant concerns. There is a need for innovative approaches to drug discovery and development, including the identification of new drug targets, optimization of drug formulations, and exploration of combination therapies. By investing in research and development, pharmaceutical companies can address unmet medical needs, enhance treatment outcomes, and capitalize on opportunities to introduce novel antiparasitic drugs to the market.
By Drug Type
By Route of Administration
By Distribution Channel
Geographical Analysis
*List not exhuastive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Antiparasitic Drugs Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Antiparasitic Drugs Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Antiparasitic Drugs Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Antiparasitic Drugs Market Size Outlook, $ Million, 2021 to 2030
3.2 Antiparasitic Drugs Market Outlook by Type, $ Million, 2021 to 2030
3.3 Antiparasitic Drugs Market Outlook by Product, $ Million, 2021 to 2030
3.4 Antiparasitic Drugs Market Outlook by Application, $ Million, 2021 to 2030
3.5 Antiparasitic Drugs Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Antiparasitic Drugs Market Industry
4.2 Key Market Trends in Antiparasitic Drugs Market Industry
4.3 Potential Opportunities in Antiparasitic Drugs Market Industry
4.4 Key Challenges in Antiparasitic Drugs Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Antiparasitic Drugs Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Antiparasitic Drugs Market Outlook By Segments
7.1 Antiparasitic Drugs Market Outlook by Segments
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
8 North America Antiparasitic Drugs Market Analysis And Outlook To 2030
8.1 Introduction to North America Antiparasitic Drugs Markets in 2024
8.2 North America Antiparasitic Drugs Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Antiparasitic Drugs Market size Outlook by Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
9 Europe Antiparasitic Drugs Market Analysis And Outlook To 2030
9.1 Introduction to Europe Antiparasitic Drugs Markets in 2024
9.2 Europe Antiparasitic Drugs Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Antiparasitic Drugs Market Size Outlook By Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
10 Asia Pacific Antiparasitic Drugs Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Antiparasitic Drugs Markets in 2024
10.2 Asia Pacific Antiparasitic Drugs Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Antiparasitic Drugs Market size Outlook by Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
11 South America Antiparasitic Drugs Market Analysis And Outlook To 2030
11.1 Introduction to South America Antiparasitic Drugs Markets in 2024
11.2 South America Antiparasitic Drugs Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Antiparasitic Drugs Market size Outlook by Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
12 Middle East And Africa Antiparasitic Drugs Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Antiparasitic Drugs Markets in 2024
12.2 Middle East and Africa Antiparasitic Drugs Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Antiparasitic Drugs Market size Outlook by Segments, 2021-2030
By Drug Type
Anthelmintics
Antiprotozoals
Others
By Route of Administration
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bayer
Cipla Ltd.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Ipca Laboratories Ltd.
Mankind Pharma
Merck KGaA
Novartis AG
Sanofi
Zydus Group
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Drug Type
By Route of Administration
By Distribution Channel
Geographical Analysis
The global Antiparasitic Drugs Market is one of the lucrative growth markets, poised to register a 5.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bayer, Cipla Ltd., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Ipca Laboratories Ltd., Mankind Pharma, Merck KGaA, Novartis AG, Sanofi, Zydus Group
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume